有证据表明,加拿大一半以上的儿科创伤患者的护理质量存在缺陷,美国和澳大利亚。缺乏对循证建议的依从性可能是由于缺乏临床实践指南(CPG)的知识所致。建议的异质性或对其质量的担忧。我们旨在系统地审查CPG对儿科损伤护理的建议并评估其质量。
我们将通过全面的搜索策略确定CPG建议,包括在线医学文献分析和检索系统,医学数据库摘录,科克伦图书馆,WebofScience,临床试验和组织网站发布有关儿科伤害护理的建议。我们将考虑CPGs,包括至少一项针对儿科损伤人群的建议,包括过去15年(2007年1月至提交前最多6个月)在高收入国家开发的任何诊断或治疗干预措施。审稿人将独立筛选标题,合格文章的摘要和全文,提取数据并使用评估指南研究和评估(AGREE)II和AGREE推荐卓越工具评估CPG及其建议的质量,分别。我们将使用建议等级评估来综合建议的证据,开发和评估(等级)决策证据框架,并在建议矩阵中显示结果。
伦理批准不是必需的,因为本研究基于现有的已发表数据。这项系统评价的结果将发表在同行评审的期刊上,在国际科学会议上提出并分发给医疗保健提供者。
国际系统评价前瞻性注册(CRD42021226934)。
Evidence suggests the presence of deficiencies in the quality of care provided to up to half of all paediatric trauma patients in Canada, the USA and Australia. Lack of adherence to evidence-based recommendations may be driven by lack of knowledge of clinical practice
guidelines (CPGs), heterogeneity in recommendations or concerns about their quality. We aim to systematically review CPG recommendations for paediatric injury care and appraise their quality.
We will identify CPG recommendations through a comprehensive search strategy including Medical Literature Analysis and Retrieval System Online, Excerpta Medica dataBASE, Cochrane library, Web of Science, ClinicalTrials and websites of organisations publishing recommendations on paediatric injury care. We will consider CPGs including at least one recommendation targeting paediatric injury populations on any diagnostic or therapeutic intervention from the acute phase of care with any comparator developed in high-income countries in the last 15 years (January 2007 to a maximum of 6 months prior to submission). Pairs of reviewers will independently screen titles, abstracts and full text of eligible articles, extract data and evaluate the quality of CPGs and their recommendations using Appraisal of
Guidelines Research and Evaluation (AGREE) II and AGREE Recommendations Excellence instruments, respectively. We will synthesise evidence on recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence-to-Decision framework and present results within a recommendations matrix.
Ethics approval is not a requirement as this study is based on available published data. The results of this systematic review will be published in a peer-reviewed journal, presented at international scientific meetings and distributed to healthcare providers.
International Prospective Register of Systematic Reviews (CRD42021226934).